A Study of CJC-1134-PC Injection in Patients With Type 2 Diabetes With Inadequately Controlled Blood Glucose Level After Metformin Monotherapy or Metformin in Combination With Insulin Secretagogues

NCT07057271 · clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
464
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Changshan ConjuChem BioPharmaceutical Research and Development (Hebei) Co., Ltd.